Peter serves as the Executive Chair of Nurami Medical and as Vice President of Business Development at Satio after 30 years at JNJ Medtech. Nurami is an Israeli electrospun nanofiber company with commercialized cranial and spinal surgery products. A ChemE by training and Army officer prior to business school, Peter started in Operations for J&J Ethicon, before moving into Sales and then Marketing and creating the JNJ Biosurgery business with hemostats and sealants such as SURGICEL and ADVASEAL. He then held executive roles within Mitek Sports Medicine and Codman Neuro and at the DePuy Synthes, JNJ Medtech, and Innovation Center levels.
In his roles within Bus Dev, Marketing, Strategy, and JNJ Innovation, Peter led evaluations across all aspects of Neuro. They spanned cranial and spinal surgery to neuro-interventional to both invasive and non-invasive neuromodulation. He remains current and is active in the ecosystem with startups and organizations such as the MassMEDIC Board and HBS Healthcare Alumni Association Board. He earned a BSE in Chemical Engineering from Princeton and an MBA from Harvard.
